These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1680995)

  • 1. Urinary kallikrein excretion in chronic renal disease with respect to salt intake and renal reserve.
    Tsai TJ; Su CJ; Chen YM; Hsieh BS; Chen WY; Yen TS
    J Formos Med Assoc; 1991 Jun; 90(6):525-30. PubMed ID: 1680995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary kallikrein excretion in non-insulin-dependent diabetes mellitus.
    Tsai TJ; Tai TY; Chen YM; Chen WY; Yen TS
    J Formos Med Assoc; 1992 Jul; 91(7):725-8. PubMed ID: 1360304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal variation in water, sodium and potassium excretion in primary glomerulonephritic patients and its relation to diurnal kallikrein excretion.
    Chen YM; Tsai TJ; Chang PI; Hsieh BS; Chen WY; Yen TS
    J Formos Med Assoc; 1990 Dec; 89(12):1052-6. PubMed ID: 1982672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sodium depletion on urinary excretion of active and inactive kallikrein in glomerulonephritic patients.
    Tsai TJ; Chen YM; Yeah FT; Hsieh BS; Chen WY; Yen TS
    J Formos Med Assoc; 1991 Jan; 90(1):105-8. PubMed ID: 1679103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal kallikrein excretion as a distal nephrotoxicity marker during cadmium exposure in rats.
    Girolami JP; Bascands JL; Pécher C; Cabos G; Moatti JP; Mercier JF; Haguenoer JM; Manuel Y
    Toxicology; 1989 Apr; 55(1-2):117-29. PubMed ID: 2652377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary kallikrein excretion in glomerulonephritis and nephrotic syndrome.
    Cumming AD; Robson JS
    Nephron; 1985; 39(3):206-10. PubMed ID: 3844632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in urinary kallikrein excretion following hemodialysis.
    Girolami JP; Bascands JL; Vega Vidalle C; Pecher C; Moatti JP; Adam A; Suc JM
    Nephron; 1991; 59(1):51-6. PubMed ID: 1944748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Salt intake and the progression of chronic renal diseases].
    Kuriyama S; Tomonari H; Ohtsuka Y; Yamagishi H; Ohkido I; Hosoya T
    Nihon Jinzo Gakkai Shi; 2003; 45(8):751-8. PubMed ID: 14737992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical study on urinary kallikrein in patients with renal diseases.
    Kimura K; Onodera K; Oike Y; Yamabe H; Numahata H; Kikuchi K; Hanada S
    Adv Exp Med Biol; 1979; 120B():549-59. PubMed ID: 517249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse relationship between renal and urinary kallikrein during chromate-induced acute renal failure in rat: urinary kallikrein excretion as a possible recovery index.
    Girolami JP; Orfila C; Pecher C; Cabos-Boutot G; Bascands JL; Moatti JP; Adam A; Colle A
    Biol Chem Hoppe Seyler; 1989 Dec; 370(12):1305-13. PubMed ID: 2619924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary endothelin-1 in patients with renal disease.
    Chu TS; Wu MS; Hsieh BS
    J Formos Med Assoc; 1998 Oct; 97(10):667-72. PubMed ID: 9830275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered renal kallikrein and renin gene expression in nephrotic rats and modulation by converting enzyme inhibition.
    Hutchison FN; Webster SK; Jaffa AA
    J Clin Invest; 1993 Aug; 92(2):1073-9. PubMed ID: 8349789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A substrate inhibitor analysis of the urinary excretion of tissue and plasma kallikreins in patients with chronic glomerulonephritis].
    Platonova LV; Poliantseva LR; Filatova MP; Paskhina TS
    Urol Nefrol (Mosk); 1990; (4):38-43. PubMed ID: 2275058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary kallikrein excretion following chronic sinoaortic denervation in conscious dogs.
    Valet P; Bascands JL; Pecher C; Cabos G; Moatti JP; Montastruc JL; Girolami JP
    Clin Exp Hypertens A; 1989; 11(2):215-31. PubMed ID: 2650929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of natriuresis in diabetic nephropathy].
    Późniak J
    Ann Acad Med Stetin; 2000; 46():241-52. PubMed ID: 11712308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on kallikrein activity in diabetic patient with hypertension caused by nephropathy].
    Kunii N
    Nihon Jinzo Gakkai Shi; 1989 Jan; 31(1):39-48. PubMed ID: 2746999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
    Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
    Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amylase to creatine clearance ratio in renal diseases.
    Andriulli A; Bergia R; Masoero G; Baiardi P; Pellegrino S; Tondolo M
    Gastroenterology; 1979 Jul; 77(1):86-90. PubMed ID: 447031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary kallikrein excretion is low in malignant essential hypertension.
    Hilme E; Herlitz H; Gyzander E; Hansson L
    J Hypertens; 1992 Aug; 10(8):869-74. PubMed ID: 1325521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.
    Chiang WC; Lin SL; Chen YM; Wu KD; Tsai TJ
    Nephrology (Carlton); 2008 Jun; 13(3):198-203. PubMed ID: 18315702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.